• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[职业医学研究中的安替比林试验——个体重现性及半衰期频率分布评估]

[The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].

作者信息

Uhlig H, Damrau J, Skölziger R

出版信息

Z Gesamte Hyg. 1989 Feb;35(2):82-4.

PMID:2741499
Abstract

The antipyrine half-life is a reliable index of biotransformation capacity of the liver. The half-lives were estimated in 137 subjects; the result was a logarithmic normal distribution of these parameters. Therefore our patients were subdivided into groups of so-called fast, intermediate and slow metabolisers (fast: t50 less than 7.6 h and slow: t50 greater than 14.9 h). Under conditions given here the intraindividual coefficient of variation was about 11.5%. The antipyrine elimination curves were calculated by a computer programme and the values were analysed statistically.

摘要

安替比林半衰期是肝脏生物转化能力的可靠指标。在137名受试者中估计了半衰期;这些参数呈对数正态分布。因此,我们将患者分为所谓的快代谢者、中代谢者和慢代谢者组(快代谢者:t50小于7.6小时,慢代谢者:t50大于14.9小时)。在此给出的条件下,个体内变异系数约为11.5%。通过计算机程序计算安替比林消除曲线,并对这些值进行统计学分析。

相似文献

1
[The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].[职业医学研究中的安替比林试验——个体重现性及半衰期频率分布评估]
Z Gesamte Hyg. 1989 Feb;35(2):82-4.
2
[Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
Przegl Dermatol. 1990 Sep-Oct;77(5):301-6.
3
Liver size in evaluating drug metabolizing capacity in man.肝脏大小在评估人体药物代谢能力中的作用。
Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):271-6.
4
Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.有或无肝硬化的酒精性患者中奎尼丁处置与安替比林消除及异喹胍代谢型的关系
Int J Clin Pharmacol Res. 1989;9(5):319-25.
5
[Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].[肝脏疾病中药物代谢酶系统的定量分析:安替比林唾液清除率与氨基比林呼吸试验的比较]
Schweiz Med Wochenschr. 1985 May 11;115(19):651-8.
6
[The mono-oxygenase enzyme system of the liver in patients with true eczema].[真性湿疹患者肝脏的单加氧酶酶系统]
Vestn Dermatol Venerol. 1990(4):46-9.
7
[Galactose and antipyrine load tests in assessing the detoxification activity of the liver].[半乳糖和安替比林负荷试验在评估肝脏解毒活性中的应用]
Minerva Dietol Gastroenterol. 1979 Oct-Dec;25(4):399-406.
8
Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.阿霉素和安替比林的血浆药代动力学及其与治疗作用和毒性作用的关系。
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S79-88.
9
[Detoxification function of the liver and body resistance in patients with acute intestinal obstruction].[急性肠梗阻患者肝脏的解毒功能与机体抵抗力]
Khirurgiia (Mosk). 1990 Dec(12):11-5.
10
[Determination of hepatic metabolic capacity: antipyrine pharmacokinetics in circulatory liver damage due to cardiac insufficiency].[肝代谢能力的测定:心功能不全所致循环性肝损伤中安替比林的药代动力学]
Dtsch Z Verdau Stoffwechselkr. 1983;43(6):255-66.